Alliance Pharma plc

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Alliance Pharma plc - overview

Established

2008

Location

Chippenham, Wiltshire, UK

Primary Industry

Pharmaceuticals

About

Alliance Pharma plc, based in the UK, is a pharmaceutical company focused on developing and marketing innovative healthcare products with a commitment to improving patient health. Alliance Pharma plc was founded in 2008 and specializes in pharmaceutical products. The company is headquartered in Chippenham, UK. It has engaged in 3 total deals, with the most recent marked by a Public to Private Secondary Buyout on January 10, 2025.


DBAY Advisors invested GBP 362. 00 mn in this round, which also represents the total amount raised by the company. Alliance Pharma offers a range of healthcare products aimed at various therapeutic areas. Their services include the development and marketing of pharmaceutical products, as well as comprehensive support for drug development processes tailored to meet regulatory standards.


Alliance Pharma generates revenue through B2B transactions with healthcare providers and distributors, engaging in service contracts that may include project-based fees or retainer agreements. Their revenue model is structured to comply with industry standards and reflects the scale of their pharmaceutical offerings. In January 2025, DBAY Advisors plans to fully acquire Alliance Pharma from previous partners for approximately GBP 362. 00 mn, indicating a strategic shift towards private ownership.


The company aims to leverage this funding to expand its product offerings and enter new markets, focusing on enhancing its presence in North America and Asia by 2026.


Current Investors

Ampersand, Resolian

Primary Industry

Pharmaceuticals

Sub Industries

Specialty Pharmaceuticals, Pharmaceutical Research & Development

Website

www.alliancepharmaco.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Alliance Pharma plc - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Public to Private, Secondary BuyoutAnnouncedAlliance Pharma plc-
Add-on, Corporate Carve Out, Trade SaleCompletedResolian-
Add-onCompletedAlliance Pharma plc-
GrowthCompletedAlliance Pharma plc-

Displaying 1 - 4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.